Objective 38 Motivated by recent calls to use electronic health records for research, we reviewed the application 39 and development of methods for addressing the bias from unmeasured confounding in longitudinal 40 data. 41 42 Design 43 Methodological review of existing literature 44 45 Setting 46 We searched MEDLINE and EMBASE for articles addressing the threat to causal inference from 47 unmeasured confounding in nonrandomised longitudinal health data through quasi-experimental 48 analysis. 49 50 Results 51
Introduction
Methods described as the quasi-experimental (QE) approach 4 , can be deployed to account for 109 confounding by unobservable characteristics. These do not attempt to directly adjust for resulting 110 bias, but use available information to achieve this indirectly under certain conditions and 111 assumptions. The aim of this systematic review is to review current practices in dealing with 112 unmeasured confounding in individual-level longitudinal health data and to capture methodological 113 developments in this area. While previous systematic reviews have been conducted to look at use 114 of propensity score methods for measured confounders 5,6 , we are unaware of any systematic 115 review comparing use of methods for addressing unmeasured confounding in non-randomised, 116 longitudinal data. We were particularly interested in how an individual's history could be leveraged 117 to evaluate the effects of unmeasured confounding and how the extra longitudinal information 118 could be incorporated to improve adjustment for confounding bias. We intend for this review to 119 contribute to the development of best practice in addressing unmeasured confounding in 120 longitudinal data. The results should therefore help inform researchers intending to utilise "big 121 data" from electronic health records. Our search strategy was informed by, but not limited to, known methods for addressing 128 excluded. Studies based on case-only designs, including the case-crossover design and the self-142 controlled case-series design, in which confounding is controlled by making comparisons between 143 exposed and unexposed periods for the same individual were also excluded. Observational studies 144
were not excluded based on the exposure under study so studies into the effects of passive 145 exposures (medical conditions, environmental exposures etc) were included alongside studies of 146 both the intended and adverse effects of active interventions. We note that good proxies for 147 unmeasured confounding, or observed variables that sufficiently describe a latent variable such as 148 frailty, would be preferable to dealing with the bias resulting from unmeasured confounders. If 149 suitable proxies are identified and recorded, then there are in effect no unobserved confounders and 150 the proxies could simply be adjusted for in the analysis, obviating the need for methods to adjust 151 for the unobserved confounders. For this reason, adjustments for proxies of unmeasured 152 confounders, including high-dimensional propensity scores, did not fall within the scope of this 153 study. To be consistent with the "big data" theme of EHRs, a minimum sample size of 1000 154 participants was applied. This also set a minimum condition for the application of Instrumental 155
Variable (IV) and Regression Discontinuity (RD) designs stipulated in the Quality of Effectiveness 156
Estimates from Non-randomised Studies (QuEENS) checklist. Finally, we only accepted analyses 157 of individual level data. We were aware that some studies may use analytical methods, such as 158 difference-in-differences that aggregate the data at a treatment-group level. We therefore only 159 included those studies, in which the same patients could be tracked over the time-frame of the 160 sample. Conversely, some methods, such as instrumental variable analysis, make no explicit 161 demands for longitudinal data at the patient level. However, we included such studies where the 162 sample was based on the availability of patient-level longitudinal information, with a history 163 possibly but not necessarily preceding the time of exposure. We did not discriminate between data 164 sources, as patient-level data will often arise from medical insurance claims in the US, as opposed 165 to clinically-purposed databases in other countries. 166
Only studies written in English were included. 167
168
The following publication types were excluded from the review: 169  systematic reviews of primary studies. Studies retrieved from the searches were selected for inclusion through a two-stage process 178 according to the inclusion/exclusion criteria specified above. First, abstracts and titles returned by 179 the search strategy were screened for inclusion independently by two researchers. In case of doubt, 180 the article in question was obtained and a subsequent judgement on relevance was based on the full 181 article. Disagreements were resolved by discussion, with involvement of a third reviewer when 182 necessary. Following the initial screening, full texts of identified studies were obtained and 183 screened firstly by a single reviewer. In case of doubt, a second reviewer decided on the suitability 184 of a paper. Where multiple publications of the same study were identified, data were extracted and 185
reported as a single study. 186 187
Evidence synthesis

189
The details of each study's design and methodology and the key characteristics of the data source 190 were tabulated and discussed. We present a summary of the methods we found that can mitigate for 191 confounding, or its synonyms as unmeasured, unobserved, hidden or residual. We note the 192 historical frequency and context of the application of those methods, to comment on progress in 193 causal inference and identify directions for future research. 194
Results
196
Included studies
198
Our searches returned 734 unique titles and abstracts, with 275 papers retrieved for detailed 199 consideration Of the 275 studies eligible for a full-text review, 154 were excluded (see flow 200 diagram: Figure 1 ). 201
202
A total of 121 studies were identified as performing a QE analysis on non-randomised longitudinal 203 data on human subjects, identifiable at an individual level, and so included for a full review of the 204 text (Appendix B). 205
206
The QE methods identified in the review are summarised inTable 1. The most frequent method was 207 instrumental variable analysis (IVA) found in 86 of the studies (Figure 2 )a method that uses an 208 unconfounded proxy for the intervention or exposure. For successful adjustment, the proxy or 209 instrument should be strongly, causally associated with the exposure or intervention, and the 210 instrument should only affect the outcome through the exposure. In addition to IVA, three of these 211 also applied difference-in-differences (DiD)a method that typically uses pre-exposure outcomes 212 to adjust for unmeasured confounding and assumes any trends unrelated to the exposure are the 213 same in both groups. Seven more studies derived estimates from a combination of both IVA and 214 DiD, two of which assumed an absence of higher order autocorrelation to use lagged observations 215 of the treatment variable as an instrument. Beside the 11 studies applying DiD either in conjunction 216 with or in addition to IVA, we identified a further 21 studies, in which the sole QE method was 217 recognised as a DiD approach. 218
219
We found five studies applied the prior event rate ratio method, a before-and-after approach that 220 can be aggregated to the treatment level for survival or rate outcomes and analogous to DiD. In all 221 five cases the methods were applied to longitudinal, individual patient data. Similarly regression 222 discontinuity (RD) was used for such data in three of the studies included for review. Another three 223 focused on propensity score calibration (PSC). One study introduced perturbation testing and 224 perturbation analysis, while another discussed the use of negative control outcomes. 225 226
Studies excluded at full text 227 228
The principal reason for exclusion in 94 of the studies, according to our eligibility criteria, was the 229 absence of longitudinally observed, non-randomised outcomes on all individually identifiable 230 persons, although other characteristics may also have justified their exclusion. No particular 231 method was associated with the absence of longitudinal data on identifiable individuals with this 232 studies in this exclusion category comprising 59% DiD and 28% instrumental variable analyses 233 compared, respectively, to 53% and 32% of all 154 of the rejected studies. Having fewer than 1000 234 longitudinally observed individuals excluded 23 studies, among which those using instrumental 235 variable analysis (IVA) numbered 15. Seven were excluded for not employing a QE method for 236 unmeasured confounding. Five studies presented exploratory analyses without a focused clinical 237 question; five were either method reviews or commentaries without an application of methods to 238 data; one study duplicated a dataset already marked for inclusion, while another failed to specify 239 the instrumental variable used. Of particular note were the 18 studies using the DiD approach that 240 were excluded because no explicit justification was made for using the method to address 241 unmeasured confounding, or any of its synonyms. In these studies, justification of the method was 242 centred more on econometric concerns over time trends, and presented in terms of controlling for 243 those trends rather than pre-existing differences between the control and exposed group. So far studies have been categorised according to their identified QE method. However, certain 248
properties are shared across some of the methods, and can be classified according to how they 249 reconcile their specific assumptions with the information offered by the structure of big, 250 longitudinal data that typifies EHRs. In particular, we organised our results around how each 251 method had incorporated longitudinal information, and the assumptions required. The stable of 252 before-and-after methods, that includes PERR and DiD, implicitly incorporates longitudinal 253 information. Thereafter the challenge is how to relax the assumption of time-invariant confounding. 254
Conversely, IVA is not uniquely applicable to longitudinal data, but we were able to broadly 255 classify the types of instruments used ( Table 2) , some of which did utilise longitudinal information. 256
We found out of the total 121 studies, 77 incorporated some element of longitudinal information 257 into their analysis. 258 259
Incorporation of external/additional data 260 261
The propensity scores (PS), the predicted probability of exposure or treatment conditioned on 262 measured confounders,were used in the seminal work on propensity score calibration (PSC) by 263
Stürmer to calibrate an error-prone PS against a gold-standard PS and hence arrive at an inference 264 for the level of unmeasured confounding bias 7 . The two subsequent PSC papers examined the 265 tenability of the method's assumptions, firstly using simulated data to evaluate the conditions 266 necessary to violate the surrogacy assumption 8 . The second primarily used simulated data and 267 applied the results to registry data to demonstrate a framework for determining size and direction of 268 bias from one measured and one hidden confounder 9 . 269 270
High-dimensional data 271 272
Since PSC collapses multiple, potential confounding variables down to the single dimension of a 273 propensity score, the three PSC papers can also be considered a means of dealing with high-274 dimensional data. In addition to these, our review also included a novel data-mining approach that 275 proposed to exploit the many factors (perturbations) that may be weakly associated with the 276 unmeasured confounders from a high dimension dataset 10 , for which longitudinal data may 277 mitigate for incorrect adjustment of a collider. Perturbation analysis was successfully demonstrated 278 on simulated data, although accidental inclusion of a measured confounder required many more 279 perturbations to correct the resulting bias. Both the perturbation method and PSC were also 280 proposed as sensitivity analyses. 281 282
Quasi-experimental adjustment without longitudinal assumptions 283 284
Those studies characterised as using a QE method without any longitudinal dimension were PSC 285 and PT as described above. We also added to this category 11 examples of Mendelian IVA 11-21 286 plus 32 other IVAs without historic or lagged instruments . While time-based instruments may 287 at first seem longitudinal, these instruments, such as date of therapy, would need to be related to 288 previous exposures or outcomes to be considered longitudinal. In some cases, survival times or rate 289 data were used, but such outcomes do not intrinsically imply longitudinal adjustment for 290 confounding. In spite of these "cross-sectional" approaches, all studies were based on some form of 291 longitudinal data at the person level, as demanded by our inclusion criteria. Among the 43 non-292
Mendelian IVA papers in this non-longitudinal category, one study adjusted for non-longitudinal 293 fixed effects within twins 39 . In another three, discussed below, the analysis was supplemented with 294 DiD 38,47 , and with IVA applied to first-differences 54 . 295
296
One study examined the effect of lagged, cumulative exposure to radiation on lung cancer in 297 uranium miners and nuclear workers 55 . The problem of unmeasured confounding was addressed 298 using a method developed in earlier work that proposed negative control outcomes and exposures 299 as a means of both detecting and potentially resolving confounding bias 56 . Here the choice of death 300 due to chronic obstructive pulmonary disorder as a negative control outcome was informed by 301 clinical knowledge of there being no direct relationship with the exposure except through the 302 possible confounder, smoking. Given a plausible negative control outcome or exposure, the method 303 offers at least a means of testing for confounding, and potentially a method of adjustment under the 304 assumption that the association between the unmeasured confounder and the negative outcome is 305 similar in magnitude to that between the same confounder and the outcome of interest. 306 307
Quasi-experimental adjustment assuming time-invariant longitudinal information 308 309
We found 36 IVA studies that used lagged information or history about the individuals' exposure 310 as instruments 54,57-92 . One study had recourse to the random assignment from a previous study, and 311 used this as an instrument 69 . Except for that and four other different exceptions, the instruments 312 were all based at least in part on the previous intervention, or history of interventions, of the 313 clinician or healthcare facility. Characteristics of the clinician or facility may be chosen as 314 instruments as they are more likely to affect the treatment only. This avoids direct associations with 315 the individual and their outcome, and so better enforces the exclusion restrictionthe exclusion of 316 the instrument's association with the outcome except through the treatment under study. While no 317 assumptions are made about the dependence of confounding on time, the strength of the instrument 318 clearly rests on a significant association between previous treatment(s) and the current treatment 319 under investigation. In this regard, if the strength of an instrument varies with time, this may 320 undermine its utility. 321
322
In total, 24 studies also incorporated longitudinal information through the stable of methods that, in 323 an abuse of terminology, we collectively referred to as the DiD approach. These included the 18 324 examples cited as using DiD regression 93-110 alone, and four fixed effects (FE) [111] [112] [113] [114] . Either 325 through fixed effects at the individual level or through aggregate-level regression operationalizing 326 the DiD approach, these methods "ignore" the effect of confounding, which is assumed to be time-327 invariant. At the individual level, time invariant confounding can be ignored by assigning nuisance 328 dummy variables for each individual, or cancelled out through demeaning the observations, or 329 through the first differences of observations on each individual. Two of the studies also extended 330
DiD to allow different exposure effects and trends across two-level sub-groups in the higher-order 331 contrast of difference-in-difference-in-differences 95, 106 . Fourteen studies also adjusted for 332 individual-level fixed effects either through direct inclusion of their covariates, or through 333 matching or weighting on the propensity score of the covariates. This was perhaps a more rigorous 334 and precise approach, accounting for known confounders, and yielding smaller standard errors for 335 the estimated treatment effect. However, an assumption of time-invariant confounding was still 336 required, with a null difference between exposure groups in the prior period being evidence of 337 adjustment for time-invariant confounding only. Two of the 24 DiD studies also re-analysed their 338 data using IVA 38, 47 , which provided an albeit limited opportunity to compare the relative 339 performance of these methods. In the study by Schmittdiel et al. of how statins delivered by mail 340 order affects cholesterol control 47 , the intervention coefficient from modelling the single main 341 outcome was larger through DiD analysis and its standard error smaller than those from IVA, large 342 standard errors being a feature of weak instruments. The study by Lei and Lin investigated the 343 effect of exposure to a new medical scheme on 15 health outcomes and rates of health-service 344 utilisation 38 . The effects were either not significantly different from the null or were significant and 345 of similar magnitude with similar standard error except for two outcomes, where the effect size was 346 significantly larger for IVA. 347 348 Time-invariant confounding, also known as the parallel trends assumption, was relaxed by 349 including dummy variables for the year and its interaction with the treatment dummy in a fixed-350 effects analysis, which allowed the unobserved trend to vary between exposure groups 113 using 351 methods developed in economics and therefore not captured by this review 115, 116 . The results from 352 this DiD with differential trend model were presented alongside those from the simple pooled DiD 353 model and DiD with individual fixed-effects for the effect of financial incentives in care services. 354
Tests confirmed parallel trends could be assumed in three outcomes, but out of the five outcomes 355 presented, four were statistically significant and in all, the estimated effect size by differential 356 trends was greater. 357
358
Our review also included six studies applying the prior event rate ratio method, a before-and-after 359 analogue applicable to survival and rate data 117-122 . The first two published were the seminal 360 presentation of the method applied to registry data. Also included was a comprehensive evaluation 361 under which bias was shown to increase with a greater effect of the prior events on subsequent 363 exposure or intervention. When prior events strongly influence the likelihood of treatment, the 364 exposure effect from the PERR method can be more biased than estimates from conventional 365 methods 121 . The problem was re-examined in a recently published study, which provided a more 366 general statistical framework for PERR adjustment and considered the potential for generalising the 367 method to allow more flexible modelling 122 . 368 369
Dynamic, longitudinal quasi-experimental methods and time-varying information 370 371
While regression discontinuity (RD) could suggest a longitudinal design, this is not exclusively so, 372 and two RD studies were excluded because of this (one applied to spatial data while the other data 373 was not longitudinal). Of those included all three could be said to accommodate time varying 374 trends 123-125 , and two of these were nested within a pre-post design: Zuckerman et al. were explicit 375 in their methodological study in identifying the robustness to time-varying confounding, in which 376 inhaler use in asthmatic patients was served as both the outcome variable in the post-test period as 377 well as the assignment variable in the pre-test period 125 . In the study of the effect school-leaving 378 age on mortality by Albouy, different slopes were modelled for the assignment variable, year of 379 birth, after the cut-off date 123 . This acknowledged different maturation rates after assignment. 380
However, as long as the assumptions of the method were met, assignment should have been as 381 good as randomised, and so no further assumptions about the temporality of confounding was 382 required. While choice of method in each study often rested on which extra information was available to 403 address the issue of unmeasured confounding, method selection may also have been informed by 404 the research area. The negative control method had its origins in epidemiology, with applications to 405 occupational health policy. Likewise, the PERR method was developed exclusively on health data, 406 with applications to drug safety and public health policy. Reflecting their origins in health 407 econometrics, some studies were published in journals partially or entirely dedicated to the subject, 408 with 15 published 38, 54, [93] [94] [95] 98, 103, 104, [111] [112] [113] [114] 126, 127, 130 in this field out of the 32 studies using DiD and 409 29 23, 24, [28] [29] [30] 32, 33, 36, 41, 46, 48, 49, 51, 52, 66, [69] [70] [71] [72] 77, 81, 84, 86, 135 out of the 86 using IVA. Under the inclusion 410 criteria, all studies had health outcomes or interventions. Mendelian IVA necessarily includes 411 genetic information, and all were published in health-related journals. In contrast, all three studies 412 using RD were published in health econometric journals. 413
414
Before implementing one of the proposed methods, a natural first step is for the researcher to try to 415 assess how much bias from unmeasured confounding is likely to be present. While many of the 416 included studies reported raw or unadjusted descriptive estimates, bias estimation was limited 417 either to considering the contribution from known confounders, including those summarised as a 418 propensity score, or to methods, such as perturbation testing/analysis and negative controls 419 methods, in which bias evaluation is an incremental step in adjustment. Under the assumption of 420 time-invariant confounding, the difference-in-differences method may potentially offer a way of 421 evaluating bias by modelling group differences in the pre-exposure period. However, few studies 422 evaluated hidden bias in this way 47, 96, 112 . The regression formulation of the DiD method effectively 423 by-passes separate analysis of the prior period. Instead studies often discussed the within-group 424 changes over time. Similarly, the prior-period estimate from the PERR method implicitly offers an 425 evaluation of confounding bias under the same assumptions, yet none of the studies presented 426 information on outcomes in the prior period in this way. A direct evaluation of unmeasured 427 confounding is less straight-forward in IVA, with further diagnostic tests only recently developed 428
for the association between instrument and confounders 136, 137 . This review examined the application of methods to detect and adjust for unmeasured confounding 433 in observational studies, and was motivated by recent calls to utilise EHRs. Most of the reviewed 434 studies used more established methods such as DiD and particularly IVA. We summarised how 435 studies exploit the longitudinal information afforded by EHRs. 436
437
It may be tempting to view electronic health records and medical insurance claims data as a 438 problem of large observational data, and hence search for solutions through data mining. However, 439 ethics governing patient data collection, plus limited clinician time is likely to preclude data with 440 very large dimensions. For that reason, it is doubtful there would be enough dimensions for a 441 method like Perturbation Analysis (PA) to be a practical solution. In addition, a greater number of 442 variables would likely include enough information about the confounders to obviate the need for 443 further adjustment through PA. More generally, the purpose of EHRs primarily as an administrative 444 tool limits the scope for data mining of known confounders. Similarly, limited availability of gold-445 standard datasets may have confined the use of external data, as in PSC, to but a few examples. 446
447
We were surprised by the number of studies using IVA alone. While Mendelian randomisation has 448
its advantages for many studies as a reasonable guarantor of the exclusion restriction, in general 449 IVA typically suffers from the weak-instrument problem, resulting in large standard errors and 450 wide confidence intervals. Longitudinal data offer an opportunity to reinforce the exclusion criteria 451 by choosing historical or lagged instruments. However in doing so, the causal structure needs to be 452 understood to avoid opening up "back door" paths and inducing further bias 54 . DiD arguably offers 453 advantages over IVA in being more intuitive and easier to conceptualise, and with the longitudinal 454 data in EHRs it should be inherently easier to work with prior observations than to identify strong 455 instruments. Even though before-and-after methods are not subject to the imprecision of weak where this can be reasonably applied. Another concern over and above the usual technical 472 challenges of applying the RD method is that in spite of heath records promising ample data, the 473 sample would need to be reduced to an interval around the cut-off that ensures exchangeability of 474 the two treatment groups. In this case generalisability would be restricted to individuals with 475 characteristics found in the interval. As with RD, PERR was another method that was found in 476 relatively few studies. This may have been in large part due to its recent development, rather than 477 any technically demanding aspect of its application, since it simply extends the before-and-after 478 approach of DiD to survival and rate data -outcomes that are common enough in health research. 479
However, the PERR approach does require strong assumptions including time-invariant 480 confounding and the absence of an effect of prior events on likelihood of future treatment 122 . 481
482
Methods such as IVA and DiD have their origins in the sphere of econometrics, where randomised 483 experiments are rare. We found that in importing DiD, some of the studies failed to explicitly 484 acknowledge the problem of confounding bias. Instead justification for the method was presented 485 in terms of the common trends assumption. Discussion of possible confounding bias is regarded as 486 essential by most QA toolkits for observational data, and it is important that health researchers 487 explicitly recognise this threat to the internal validity of non-randomised studies. Conceptually a 488 non-temporal analogue of DiD would be the NCO method, which itself was presented foremost as 489 a method for detecting unmeasured confounding. Given doubts over satisfying necessary 490 assumptions for their implementation, authors of this method along with propensity score 491 calibration and perturbation analysis have suggested that, as sensitivity analyses, these can at least 492 offer an insightful complement to QE adjustment. 493
494
Choosing between methods to reduce unmeasured confounding bias is challenging and we found 495 few studies that directly compare methods. The performance of different methods will depend on 496 factors such as the nature of the underlying confounding, the type of exposure and outcome, and 497 the sample size 138 The type of data available will also guide the choice of method. For example, 498 the instrumental variable method requires a suitable instrument and DiD / PERR require data on at 499 least two periods. In practice, no one method is likely to be best suited to all problems, and it is 500 essential for investigators to carefully assess the potential biases in each proposed study, where 501 possible tailoring the methods or combination of methods to address these biases 139 . Our review 502 has highlighted how use of longitudinal information is one additional and potentially important 503 consideration in this process. 504 505 While our review focussed on the problem of adjustment using analytic methods, many problems 506 associated with observational data may be pre-empted by use of an appropriate study design 140 . 507
Before choosing an appropriate analytic method, it is recommended that investigators carefully 508 identify and match individuals for the control and intervention groups in order not to exacerbate 509 any bias 3 . The importance of study design is often discussed with a view to minimising 510 confounding bias from unmeasured sources, with the subsequent adjustment accounting for 511 observed confounders only 141 , usually through the matching, weighting or adjustment of propensity 512 scores 142 . Where the success of the design remains in doubt, or its criteria cannot be fully met, then 513 investigators will inevitably need recourse to some of the alternative methods reviewed in this 514 report. 515
516
The reviewed studies did not seek to distinguish between the different mechanisms of bias. 517
Confounding by indication, deemed intractable by many researchers using the observed data 143 , 518 was seen to create additional sources of bias in two separate simulation studies applying the 519 "longitudinal" method of PERR, when an association was modelled between prior events and 520 treatment status in the study period 121, 122 . Another common form of selection bias in 521 pharmacoepidemiologic studies is the healthy user bias and this works in the opposite direction to 522 confounding by indication, distorting treatment-outcome associations towards the treatment 523 looking beneficial 3 . Further research is needed to understand how each of the methods in this 524 review is affected by the different types of confounding. 525 526 An inherent limitation of this large, wide-ranging review is that it precluded meaningful data 527 synthesis due to the mix of different data and study types. Furthermore, we could only find a few 528 examples where the performance of different methods was compared within the same study. We 529 also stipulated in the inclusion criteria that unmeasured confounding, or any of its synonyms, 530 should be given as justification for methods in its adjustment. This may have inadvertently 531 excluded some papers, where justification was implicit, but good practice in health research 532 demands acknowledgement of this source of bias where applicable. While our search terms were 533 specific to the scope of our review, we accept that this may have inadvertently excluded relevant 534 methods and studies. Some methods, such as negative control outcomes, that were identified in the 535 original search were not included as explicit terms in the search strategy, and further secondary 536 searches may have uncovered additional studies using these methods. We also acknowledge that 537 there may be other relevant methods for addressing unmeasured confounding that have been missed 538 by the search strategy. Consequently, we made inferences about the relative application of methods 539 with caution. However, we were surprised so many studies focussed solely on IVA as the sole 540 means of adjustment. A similar conclusion was echoed by a different review on regression 541 discontinuity designs that found interest was growing in RD only as recently as 2014 144 . 542 543 By choosing to focus on methods with an independent control arm for each treatment, our review 544 excluded case only designs including case-crossover designs (CCO) and the self-controlled case-545 series design. This class of methods addresses unmeasured confounding by making comparisons 546 within individuals so that each individual acts as his or her own control. Another case-only design, 547 the case-time control design, is an extension of the CCO design that uses information from a 548 historical control group in a similar way to the PERR method. These approaches are reviewed by 549 These recommendations offer a useful checklist for researchers developing methods for addressing 563 unmeasured confounding in observational studies. Of particular relevance in the context of this 564 review is the need for more extensive evaluation and comparison of the emerging methods in a 565 range of settings. The review also addresses the need for methodological guidance through 566 highlighting the potentially important role of longitudinal information in addressing confounding 567 bias and has identified this as an area for further development. 568
Conclusions
570
Our review showed how seminal work in econometrics has influenced practice in dealing with 571 unmeasured confounding in clinical and epidemiological research. Although the issue of 572 unmeasured confounding is widely acknowledged, we found that longitudinal information in 573 observational studies appears under-utilised. Lagged and historical characteristics associated with 574 the treatment may help enforce the exclusion restrictions of instrumental variables under the 575 appropriate causal structures, while before-and-after methods, such as DiD and PERR, afford an 576 intuitive approach without the imprecision of weak instruments. Furthermore, they offer a direct 577 evaluation of time-invariant confounding bias. The most robust methods we found applied 578 instrumental variable analysis to the fixed effects difference-in-differences method, where such 579 suitable instruments or difference lagged variables could be assumed to satisfy the exclusion 580 restriction. While there are sometimes good technical reasons for choosing one mode of analysis 581 over another, many questions remain over the most appropriate methods. All methods rely on 582 assumptions, but little guidance is available to applied researchers as to the empirical settings in 583 which particular methods can be safely used. Few studies directly compare different methods and 584 more research is needed to the establish the relative performance of the methods in realistic 585 Universities. The funders had no role in study design, data collection and analysis, decision to 599 publish, or preparation of the manuscript. The views expressed in this publication are those 600 of the authors and not necessarily those of the NHS, the NIHR or the Department of Health. 601 Other [light grey] includes regression discontinuity, prior event rate ratio method, propensity score calibration, perturbation analysis, negative control outcomes, fixed effects with IVA and dynamic panel models. Note: the low frequencies in 2015 was attributable to the May cut-off for inclusion in that year.
Method
Description Obstacles to implementation Frequency of methods
Instrumental variable analysis (IVA)
Upon identification of a suitably strong instrument, the influence of bias may be reduced through post-hoc randomisation. The instrumental variable should be highly determinant of the intervention or treatment received, while satisfying the exclusion assumption of being independent of the outcome other than through the treatment (Wright 1928; Angrist 1991) .
In practice, finding an instrument with a sufficiently strong treatment association is a stumbling block in many analyses (Bound, Jaeger, and Baker 1995; Baser 2009 ). Association of the instrument with the outcome exclusively through the treatment is an untestable assumption, particularly if an indirect association exists through an unmeasured covariate.
79
Difference-indifferences (DiD) A biased effect estimate between two treatment groups may be corrected by the same estimates from a treatment-free period prior to the exposure, which should be a measure of the confounding bias contributed to the treatment effect (Ashenfelter and Card 1984) . Aggregated at the treatment group level, this is operationalised in regression as a periodtreatment interaction. At an individual level, demeaning, first-differencing or dummy variables for each individual may yield bias-free fixed effects, contingent on assumptions.
The method is contingent on the availability of repeated outcomes in both periods and invokes a time-invariant confounding assumption: that the confounding bias as captured by the estimated treatment effect in a treatment-free period prior to exposure is constant through to the study period.
24
Prior event rate ratio (PERR)
Analogous to the DiD method for time-to-event or rate data, a biased estimate of the hazard ratio or the incidence rate ratio is adjusted through its ratio with that from a treatment-free prior period (Tannen et al. 2008) .
As with the assumption for DiD, repeatable outcomes and a constancy of the unmeasured confounding bias is required across both periods, before and after the exposure. Prior event occurrence should not influence the likelihood of future treatment. Lagged observations of the confounded (endogenous) explanatory variable are introduced in a first-differences fixed effects analysis so that the differences of the lags become the instrumental variables in a generalised method of moments estimation.
Assumptions of IVA apply. Here the differenced lags should not be correlated with the differences in the error terms. 2
Regression discontinuity (RD)
RD is a design for analysis based on a treatment assignment determined by a cut-off applied to a continuous variable that is preferably measured with some random noise (as many clinical tests may be). The outcome can then be modelled on treatment for individuals within a certain interval from the cut-off of the assignment variable to ensure exchangeability between individuals for robust causal inference (Thistlethwaite and Campbell 1960) Where assignment is not sharply determined by the cut-off, an increase in the probability of treatment may be observed leading to a "fuzzy" version of RD. Continuity in the assignment variable is assumed, otherwise manipulation of assignment and reverse causality may be suspected. Assignment should be locally random around the cut-off and makes the weak assumption that no unobserved covariates are discontinuous around the assignment cut-off.
3
Propensity score calibration (PSC) PSC adjusts for residual confounding in the error-prone main dataset by importing information about the unmeasured confounders from a smaller, external "gold-standard" dataset (Stürmer et al. 2005) . Analysis in the main dataset is adjusted using a single dimension propensity score of the measured corrected for unmeasured confounding by regression calibration against the gold-standard propensity score.
Successful adjustment is wholly dependent on the availability of another dataset containing the exposure variable and error-free predictor, with individuals that are relevant enough to those in the main dataset and under similar enough conditions to assure sufficient overlap between the two datasets.
3 Perturbation testing/analysis (PT/PA) This data mining approach aims to mitigate for unmeasured confounding by adjusting for many measured variables that are weakly associated with the unobserved confounding variables (Lee 2014). Simulation in the single reviewed example demonstrated this may require 100's, if not 1000's of perturbation variables (PV).
This requires a very highly dimensional dataset, which may ultimately obviate the need for indirect adjustment if the most or all of the confounders are captured. Simulation demonstrated the bias may be exaggerated if a confounder is inadvertently identified as a PV, requiring many more true PVs to correct the bias. The number of PVs may exceed the available degrees of freedom necessitating clustering.
1 Negative control outcome / exposure (NCO/NCE) A negative controlis causally related to measured and unmeasured confounders affecting the exposure and main outcome, but not directly causally related to exposure and outcome themselves. As such, the negative control may be used to detect confounding bias in the main study, and potentially to indirectly adjust for this (Richardson et al. 2014) This assumes that the effect of the unmeasured confounders on the main outcome is similar to that affecting the negative control. 1 
